Errata - English

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),

In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),
AND
In Molybdenum, Method 2/Instrumental conditions: Change
(See Atomic Absorption Spectroscopy <852>.)
to:
(See Ultraviolet-Visible Spectroscopy <857>.)

In System suitability/Suitability requirements/Peak-to-valley ratio: Change
NLT 1.5 for loperamide related compounds G and H; NLT 1.5 for loperamide related compounds E and A, System suitability solution
to:
NLT 1.5 for loperamide cis-N-oxide and anhydroloperamide; NLT 1.5 for loperamide piperidinolamide and loperamide biphenyl analog, System suitability solution

In Biotin, Method 3/Solid-phase extraction: Change
anion-xchange
to:
anion-exchange
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 1/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Niacin or Niacinamide, Pyridoxine Hydrochloride, Riboflavin, and Thiamine, Method 3/Analysis: Delete
, calcium pantothenate (C₁₈H₃₂CaN₂O₁₀), and folic acid (C₁₉H₁₉N₇O₆),
AND
In the Calculate statement in Folic Acid, Method 3; Ascorbic Acid, Niacin or Niacinamide, Pyridoxine Hydrochloride, Calcium Pantothenate, Riboflavin, and Thiamine, Method 4/Analysis: Add
ascorbic acid (C₆H₈O₆),

In Bicarbonate/B.: Change
(1:20)
to:
(1 in 20)
AND
In Borate/A.: Change
(1:50):
to:
(1 in 50):
AND
In Calcium/A.: Change
(1:20)
to:
(1 in 20)
AND
In Carbonate/B.: Change
(1:20)
to:
(1 in 20)
AND
In Chloride/B.: Change
(1:100),
to:
(1 in 100),
AND
In Cobalt/A.: Change
(1:20)
to:
(1 in 20)
AND
Change
(1:10)
to:
(1 in 10)
AND
In Tartrate/A.: Change
(1:20).
to:
(1 in 20).

In Table 3: Delete
Propofol related compound B^b 0.8 1.0 0.05
AND
Change
Propofol related compound A^c
to:
Propofol related compound A^b
AND
Change
^b2,6-Diisopropylbenzoquinone.
^c3,3′-5,5′-Tetraisopropyldiphenol.
to:
^b3,3′-5,5′-Tetraisopropyldiphenol.

In Test 1/Analysis: Change
dissolved at time point (i):
Result_i = (r_U/r_S) × C_S × V × D × (1/L) × 100
to:
dissolved:
Result = (r_U/r_S) × C_S × V × D × (1/L) × 100
AND
In Test 3/Analytical procedure 1/Analysis: Change
V = volume of Medium, 900 mL
to:
V = volume of Medium 1, 900 mL
AND
In Test 3/Analytical procedure 2/Analysis: Change
V_M = volume of Medium, 900 mL
to:
V_M = volume of Medium 1, 900 mL
AND
In Test 3/Analytical procedure 3/Blank: Change
Medium
to:
Medium 2
AND
In Test 3/Analytical procedure 3/Analysis: Change
V_M = volume of Medium, 900 mL
to:
V_M = volume of Medium 2, 900 mL

In Dissolution <711>: Change
Sample solution: Sample per the chapter. Dilute with Medium to a concentration that is similar to the Standard solution.
Tolerances: NLT 75% (Q) of the labeled amount of dicloxacillin (C₁₉H₁₇Cl₂N₃O₅S) is dissolved.
to:
Sample solution: Sample per the chapter. Pass a portion of the solution under test through a suitable filter. Dilute with Medium to a concentration that is similar to the Standard solution.
Instrumental conditions
Mode: UV-Vis
Tolerances: NLT 75% (Q) of the labeled amount of dicloxacillin (C₁₉H₁₇Cl₂N₃O₅S) is dissolved.